ABBV · AbbVie Inc.
$256.91
-0.01 (0.00%)
At close · Jul 27
Market Cap
$458.24B
Shares
1.77B
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-06 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-22 | 2026-06-18 | |
| 8-K | 2026-05-12 | 2026-05-08 | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-04-29 | — | |
| 8-K | 2026-04-03 | — | |
| DEF 14A | 2026-03-23 | 2026-05-08 | |
| 8-K | 2026-03-04 | — | |
| 8-K | 2026-02-26 | 2026-02-24 | |
| 10-K | 2026-02-20 | 2025-12-31 | |
| 8-K | 2026-02-04 | — | |
| 8-K | 2026-01-07 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-10-31 | — | |
| 8-K | 2025-10-03 | — | |
| 8-K | 2025-09-11 | — | |
| 10-Q | 2025-08-04 | 2025-06-30 | |
| 8-K | 2025-07-31 | — | |
| 8-K | 2025-07-03 | — | |
| 8-K | 2025-05-13 | 2025-05-08 | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| 8-K | 2025-04-25 | — | |
| 8-K | 2025-04-03 | — | |
| DEF 14A | 2025-03-24 | 2025-05-09 | |
| 8-K | 2025-02-26 | — | |
| 8-K | 2025-02-19 | 2025-02-18 | |
| 10-K | 2025-02-14 | 2024-12-31 | |
| 8-K | 2025-02-14 | 2025-02-13 | |
| 8-K | 2025-02-05 | 2025-01-30 | |
| 8-K | 2025-01-31 | — | |
| 8-K | 2025-01-10 | 2025-01-09 | |
| 8-K | 2025-01-06 | — | |
| 8-K | 2024-12-13 | 2024-12-11 | |
| 10-Q | 2024-11-04 | 2024-09-30 | |
| 8-K | 2024-10-30 | — | |
| 8-K | 2024-10-03 | — | |
| 8-K | 2024-09-10 | 2024-09-06 | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-07-25 | — | |
| 8-K | 2024-07-03 | — | |
| 8-K/A | 2024-05-08 | 2024-02-14 | |
| 10-Q | 2024-05-03 | 2024-03-31 | |
| 8-K | 2024-04-26 | — | |
| 8-K | 2024-04-03 | — | |
| DEF 14A | 2024-03-18 | 2024-05-03 | |
| 8-K | 2024-02-26 | 2024-02-22 | |
| 10-K | 2024-02-20 | 2023-12-31 | |
| 8-K | 2024-02-20 | 2024-02-14 |
Showing 1–50 of 138 filings
Key facts
CIK
1551152
CUSIP
00287Y109
13F (30d)
1654 filings
1600 filers
Visit website
Investor relations